What is the role of eculizumab in the treatment of antiphospholipid syndrome (APS)?

Updated: Sep 30, 2018
  • Author: Suneel Movva, MD; Chief Editor: Herbert S Diamond, MD  more...
  • Print
Answer

Case reports have described the use of eculizumab, a humanized monoclonal antibody against C5 complement protein, in CAPS, and in aPL-positive patients undergoing renal transplantation. [28]


Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!